Log in or Sign up for Free to view tailored content for your specialty!
Infection Control News
Study finds ceftolozane/tazobactam safe, effective for children with cUTIs
A phase 2 randomized clinical trial found that ceftolozane/tazobactam was a safe and effective option for the treatment of children with complicated UTIs, researchers reported in The Pediatric Infectious Disease Journal.
FDA committee endorses plan to simplify COVID-19 vaccines
An FDA advisory committee voted unanimously Thursday in favor of a plan to streamline and simplify COVID-19 vaccine compositions in the United States by replacing initial, primary doses with the bivalent vaccines currently used as boosters.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: Pan-resistant gonorrhea ‘may be inevitable’ without changes
Massachusetts health officials detected a novel strain of gonorrhea with reduced susceptibility or resistance to five antibiotic classes — the first of its kind in the United States.
FDA committee recommends approval of rezafungin for candidemia and invasive candidiasis
The FDA Antimicrobial Drugs Advisory Committee voted on Wednesday 14-1 in favor of the use of rezafungin for the treatment of candidemia and invasive candidiasis.
Extended trial data show injectable HIV regimen effective when given every 2 months
Long-acting cabotegravir and rilpivirine dosed every 8 weeks was effective and well tolerated, showing noninferiority to the standard 4-week dosing at 152 weeks, according to extended data from the ATLAS-2M trial.
Q&A: More HIV self-tests needed to bolster market, drive down cost, increase access
The FDA approved the first self-test for HIV in 2012, allowing more people to know their HIV status, but unfortunately, no company has applied for FDA clearance in the decade since.
Top in ID: Long COVID in adults; changes in antibiotic prescribing
Nearly 19 million adults in the United States may have long COVID, with some individuals reporting symptoms more than 1 year following their infection, according to results of a population-based study.
Most staff who deliver home infusion therapy not trained in infection surveillance
There has been a significant increase in the number of people receiving home infusion therapy over the last decade, but a study found that many who deliver these services have no formal training in infection surveillance.
Children bore brunt of ‘early and intense’ flu season
Children were twice as likely as adults to test positive for influenza and more likely to be hospitalized for influenza this season, according to data published in MMWR.
Barriers to preventing congenital syphilis amplified by substance use, study suggests
A study of pregnant people with syphilis found that substance use during pregnancy was nearly twice as common among those who delivered an infant with congenital syphilis than among peers who did not pass the infection to their baby.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read